Publications

Publications published since 2000 from OUS - Department of Nephrology (Div Med)

223 publications found

Publications 2020

  1. Bergo KK, Larstorp AC, Hoffmann P, Hjørnholm U, Cataliotti A, Høieggen A, Rostrup M, Fadl Elmula FEM (2020)
    Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
    Blood Press
    DOI 10.1080/08037051.2020.1789446, PubMed 32633141
  2. Boenink R, Stel VS, Waldum-Grevbo BE, Collart F, Kerschbaum J, Heaf JG, de Meester J, Finne P, García-Marcos SA, Evans M, Ambühl PM, Arici M, Ayav C, Steenkamp R, Cases A, Traynor JP, Palsson R, Zoccali C, Massy ZA, Jager KJ, Kramer A (2020)
    Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy
    Kidney Int (in press)
    DOI 10.1016/j.kint.2020.05.039, PubMed 32569654
  3. Folkestad T, Brurberg KG, Nordhuus KM, Tveiten CK, Guttormsen AB, Os I, Beitland S (2020)
    Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis
    Crit Care, 24 (1), 2
    DOI 10.1186/s13054-019-2710-4, PubMed 31898523
  4. Jansz TT, Noordzij M, Kramer A, Laruelle E, Couchoud C, Collart F, Cases A, Arici M, Helve J, Waldum-Grevbo B, Rydell H, Traynor JP, Zoccali C, Massy ZA, Jager KJ, van Jaarsveld BC (2020)
    Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry
    Nephrol Dial Transplant, 35 (3), 488-495
    DOI 10.1093/ndt/gfz208, PubMed 31740955
  5. Kjeldsen SE, Os I (2020)
    Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH
    Eur Heart J, 41 (16), 1572-1574
    DOI 10.1093/eurheartj/ehz703, PubMed 31580419
  6. Kjeldsen SE, Os I (2020)
    Assessing hypertension therapies: randomization or confounding by indication?
    Nat Rev Cardiol, 17 (2), 73-74
    DOI 10.1038/s41569-019-0313-z, PubMed 31768007
  7. Ljungman S, Jensen JE, Paulsen D, Petersons A, Ots-Rosenberg M, Saha H, Struijk DG, Wilkie M, Heimbürger O, Stegmayr B, Elung-Jensen T, Johansson AC, Rydström M, Gudmundsdottir H, Petzold M, Peritonitis Prevention Study (PEPS) Trial Investigators (2020)
    Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial
    Perit Dial Int, 40 (2), 141-152
    DOI 10.1177/0896860819887626, PubMed 32063220
  8. Rognstad S, Søraas CL, Bergland OU, Høieggen A, Strømmen M, Helland A, Opdal MS (2020)
    Establishing Serum Reference Ranges for Antihypertensive Drugs
    Ther Drug Monit (in press)
    DOI 10.1097/FTD.0000000000000806, PubMed 32881780
  9. Seljelid B, Varsi C, Solberg Nes L, Stenehjem AE, Bollerslev J, Børøsund E (2020)
    Content and system development of a digital patient-provider communication tool to support shared decision making in chronic health care: InvolveMe
    BMC Med Inform Decis Mak, 20 (1), 46
    DOI 10.1186/s12911-020-1065-8, PubMed 32131808
  10. Thorsteinsdottir H, Salvador CL, Mjøen G, Lie A, Sugulle M, Tøndel C, Brun A, Almaas R, Bjerre A (2020)
    Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation
    Dis Markers, 2020, 6162892
    DOI 10.1155/2020/6162892, PubMed 32089755

Publications 2019

  1. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
    Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
    Blood Press, 29 (2), 123-134
    DOI 10.1080/08037051.2019.1684817, PubMed 31718316
  2. Drangsholt SH, Cappelen UW, von der Lippe N, Høieggen A, Os I, Brekke FB (2019)
    Beliefs about medicines in dialysis patients and after renal transplantation
    Hemodial Int, 23 (1), 117-125
    DOI 10.1111/hdi.12717, PubMed 30714322
  3. Hjørnholm U, Larstorp ACK, Andersen MH, Høieggen A (2019)
    Directly observed therapy prior to ambulatory blood pressure measurement (DOT-HTN) in uncontrolled hypertensive patients - Effect on blood pressure, safety and patient perception
    Blood Press, 28 (5), 327-335
    DOI 10.1080/08037051.2019.1633907, PubMed 31250668
  4. Kjeldsen SE, Os I (2019)
    Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?
    Hypertension, 74 (3), 497-498
    DOI 10.1161/HYPERTENSIONAHA.119.13350, PubMed 31327260
  5. Kjeldsen SE, Os I, Westheim A (2019)
    Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
    J Hypertens, 37 (5), 902-904
    DOI 10.1097/HJH.0000000000002018, PubMed 30920495
  6. Mjoen G, Abramowicz D (2019)
    What happens to the live donor in the years following donation?
    Nephrol. Dial. Transplant., 34 (8), 1289-1291
  7. Parker K, Bull-Engelstad I, Benth JŠ, Aasebø W, von der Lippe N, Reier-Nilsen M, Os I, Stavem K (2019)
    Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial
    Eur J Clin Pharmacol, 75 (11), 1503-1511
    DOI 10.1007/s00228-019-02727-9, PubMed 31359099
  8. Parker K, Bull-Engelstad I, Aasebø W, von der Lippe N, Reier-Nilsen M, Os I, Stavem K (2019)
    Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease
    Hemodial Int, 23 (3), 333-342
    DOI 10.1111/hdi.12739, PubMed 30779285
  9. Sommer M, von der Lippe N, Klow NE, Hoieggen A (2019)
    Renal fibromuscular dysplasia and hypertension
    Tidsskr. Nor. Laegeforen., 139 (4), 342-345
  10. Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
    Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
    BMC Cardiovasc Disord, 19 (1), 4
    DOI 10.1186/s12872-018-0989-8, PubMed 30611196
  11. Therkildsen J, Winther S, Nissen L, Jørgensen HS, Thygesen J, Ivarsen P, Frost L, Isaksen C, Langdahl BL, Hauge EM, Böttcher M (2019)
    Sex Differences in the Association Between Bone Mineral Density and Coronary Artery Disease in Patients Referred for Cardiac Computed Tomography
    J Clin Densitom (in press)
    DOI 10.1016/j.jocd.2019.09.003, PubMed 31668962

Publications 2018

  1. Kjeldsen SE, Os I, Nilsson PM (2018)
    Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?
    Hypertension, 72 (2), 291-293
    DOI 10.1161/HYPERTENSIONAHA.118.11455, PubMed 29967041
  2. Kjeldsen SE, Stenehjem AE, Os I, van den Borne P (2018)
    European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2016; 17: Nr. 63* Treatment of High Blood Pressure in Elderly and Octogenarians
    J. Hyperton., 22 (2), 46-48
  3. Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ (2018)
    Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
    J Thromb Haemost, 16 (10), 1953-1963
    DOI 10.1111/jth.14254, PubMed 30063819
  4. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
    Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
    Nephrol Dial Transplant, 33 (1), 102-112
    DOI 10.1093/ndt/gfw360, PubMed 27798199

Publications 2017

  1. Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
    Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
    Prog Transplant, 27 (4), 386-391
    DOI 10.1177/1526924817732020, PubMed 29187131
  2. Dupont L, Winther S, Jørgensen HS, Bomholt P, Bøtker HE, Bøttcher M, Ivarsen P, Svensson M (2017)
    Atrial function, atrial volume and cardiovascular clinical outcomes in patients with end-stage renal disease - A study of cardiac computed tomography
    J Cardiovasc Comput Tomogr, 11 (5), 389-396
    DOI 10.1016/j.jcct.2017.07.001, PubMed 28705554
  3. Kjeldsen SE, Os I (2017)
    Interventions to improve adherence of antihypertensive medication in African-Americans
    J Hypertens, 35 (6), 1164-1165
    DOI 10.1097/HJH.0000000000001249, PubMed 28441256
  4. Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
    Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
    Blood Press, 26 (6), 332-340
    DOI 10.1080/08037051.2017.1346459, PubMed 28675304
  5. Mariampillai JE, Eskås PA, Heimark S, Larstorp AC, Fadl Elmula FE, Høieggen A, Nortvedt P (2017)
    Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues
    Blood Press, 26 (3), 133-138
    DOI 10.1080/08037051.2016.1277129, PubMed 28078909
  6. Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
    Transpl Int, 30 (8), 827-840
    DOI 10.1111/tri.12973, PubMed 28436117
  7. Rizvi SMH, Aagnes B, Holdaas H, Gude E, Boberg KM, Bjørtuft Ø, Helsing P, Leivestad T, Møller B, Gjersvik P (2017)
    Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study
    JAMA Dermatol, 153 (12), 1270-1277
    DOI 10.1001/jamadermatol.2017.2984, PubMed 29049612
  8. Sagedal S, Sandvik L, Klingenberg O, Sandset PM (2017)
    β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane
    Scand J Clin Lab Invest, 77 (8), 679-684
    DOI 10.1080/00365513.2017.1397288, PubMed 29117741
  9. Schei J, Stefansson VT, Eriksen BO, Jenssen TG, Solbu MD, Wilsgaard T, Melsom T (2017)
    Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population
    Clin J Am Soc Nephrol, 12 (4), 624-634
    DOI 10.2215/CJN.09280916, PubMed 28153935
  10. Stubnova V, Os I, Grundtvig M, Atar D, Waldum-Grevbo B (2017)
    Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
    Cardiorenal Med, 7 (2), 128-136
    DOI 10.1159/000454933, PubMed 28611786
  11. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 32 (2), 348-355
    DOI 10.1093/ndt/gfw392, PubMed 28031344

Publications 2016

  1. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
    Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
    Acta Anaesthesiol Scand, 60 (8), 1170-81
    DOI 10.1111/aas.12753, PubMed 27306254
  2. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
    Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
    Crit Care, 20 (1), 314
    DOI 10.1186/s13054-016-1503-2, PubMed 27716377
  3. Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A (2016)
    Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
    Hypertension, 68 (2), 297-306
    DOI 10.1161/HYPERTENSIONAHA.116.07464, PubMed 27296995
  4. Brekke FB, Waldum-Grevbo B, von der Lippe N, Os I (2016)
    The effect of renal transplantation on quality of sleep in former dialysis patients
    Transpl Int, 30 (1), 49-56
    DOI 10.1111/tri.12866, PubMed 27696543
  5. Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
    Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
    J Ren Nutr, 27 (3), 161-168
    DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193
  6. Eskas PA, Heimark S, Mariampillai JE, Larstorp ACK, Elmula FEMF, Hoieggen A (2016)
    Drug compliance and monitoring of antihypertensive treatment
    Tidsskr. Nor. Laegeforen., 136 (10), 920-923
  7. Eskås PA, Heimark S, Eek Mariampillai J, Larstorp AC, Fadl Elmula FE, Høieggen A (2016)
    Adherence to medication and drug monitoring in apparent treatment-resistant hypertension
    Blood Press, 25 (4), 199-205
    DOI 10.3109/08037051.2015.1121706, PubMed 26729283
  8. Heimark S, Eskås PA, Mariampillai JE, Larstorp AC, Høieggen A, Fadl Elmula FE (2016)
    Tertiary work-up of apparent treatment-resistant hypertension
    Blood Press, 25 (5), 312-8
    DOI 10.3109/08037051.2016.1172865, PubMed 27124769
  9. Kjeldsen SE, Os I (2016)
    High blood pressure in US diabetic veterans with normal renal function: a plea for the design of a more powerful and conclusive outcome trial
    J Hypertens, 34 (5), 836-7
    DOI 10.1097/HJH.0000000000000896, PubMed 27027378
  10. Kjeldsen SE, Os I (2016)
    Hypertension: When should we treat hypertension in patients with diabetes?
    Nat Rev Cardiol, 13 (5), 252-3
    DOI 10.1038/nrcardio.2016.49, PubMed 27053453
  11. Kjeldsen SE, Os I, Redon J (2016)
    Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials
    J Hypertens, 34 (8), 1489-91
    DOI 10.1097/HJH.0000000000001002, PubMed 27355995
  12. Kjeldsen SE, Stenehjem A, Os I, Van de Borne P, Burnier M, Narkiewicz K, Redon J, Agabiti Rosei E, Mancia G (2016)
    Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets
    Blood Press, 25 (6), 333-336
    DOI 10.1080/08037051.2016.1236329, PubMed 27644446
  13. Kolseth IB, Reine TM, Parker K, Sudworth A, Witczak BJ, Jenssen TG, Kolset SO (2016)
    Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
    J Diabetes Complications, 31 (1), 245-252
    DOI 10.1016/j.jdiacomp.2016.06.029, PubMed 27452162
  14. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
  15. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
  16. von der Lippe N, Waldum-Grevbo B, Varberg Reisæter A, Os I (2016)
    Is HRQOL in dialysis associated with patient survival or graft function after kidney transplantation?
    BMC Nephrol, 17, 94
    DOI 10.1186/s12882-016-0316-5, PubMed 27456506

Publications 2015

  1. Amro A, Waldum-Grevbo B, von der Lippe N, Brekke FB, Miaskowski C, Os I (2015)
    Symptom Clusters From Dialysis to Renal Transplantation: A Five-Year Longitudinal Study
    J Pain Symptom Manage, 51 (3), 512-9
    DOI 10.1016/j.jpainsymman.2015.10.012, PubMed 26550937
  2. Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
    Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
    Transplantation, 99 (8), 1730-7
    DOI 10.1097/TP.0000000000000660, PubMed 25757216
  3. Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
    One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
    Clin Transplant, 29 (3), 268-76
    DOI 10.1111/ctr.12515, PubMed 25644963
  4. Kjeldsen SE, Fadl Elmula FE, Os I, Persu A, Jin Y, Staessen JA (2015)
    Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence
    Eur Heart J Cardiovasc Pharmacother, 1 (1), 48-56
    DOI 10.1093/ehjcvp/pvu009, PubMed 27533966
  5. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO (2015)
    Estimated GFR is biased by non-traditional cardiovascular risk factors
    Am J Nephrol, 41 (1), 7-15
    DOI 10.1159/000371557, PubMed 25612475
  6. Mjoen G, Holdaas H (2015)
    Selecting Appropriate Controls for Kidney Donors
    Am. J. Transplant., 15 (1), 286
  7. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
    Clin Transplant, 29 (8), 678-84
    DOI 10.1111/ctr.12565, PubMed 25982053
  8. Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
    Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
    Clin Ther, 37 (7), 1594-9
    DOI 10.1016/j.clinthera.2015.04.009, PubMed 25963997
  9. Persu A, Jin Y, Fadl Elmula FE, Renkin J, Høieggen A, Kjeldsen SE, Staessen JA (2015)
    Renal denervation in treatment-resistant hypertension: a reappraisal
    Curr Opin Pharmacol, 21, 48-52
    DOI 10.1016/j.coph.2014.12.013, PubMed 25601357
  10. Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
    High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
    Blood Press, 24 (3), 131-8
    DOI 10.3109/21695717.2015.1030889, PubMed 25901999
  11. Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
    Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
    J Hypertens, 33 (9), 1845-51; discussion 1852
    DOI 10.1097/HJH.0000000000000632, PubMed 26103130
  12. Smedbraten YV, Sagedal S, Mjoen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High Ficolin-3 Level at the Time of Transplantation Is an Independent Risk Factor for Graft Loss in Kidney Transplant Recipients
    Transplantation, 99 (4), 791-796
  13. Storhaug HM, Toft I, Norvik JV, Jenssen T, Eriksen BO, Melsom T, Løchen ML, Solbu MD (2015)
    Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study
    BMC Nephrol, 16, 210
    DOI 10.1186/s12882-015-0207-1, PubMed 26651613
  14. Waldum-Grevbo B (2015)
    What physicians need to know about renal function in outpatients with heart failure
    Cardiology, 131 (2), 130-8
    DOI 10.1159/000381012, PubMed 25966919
  15. Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
    Impact of initial dialysis modality on mortality: a propensity-matched study
    BMC Nephrol, 16, 179
    DOI 10.1186/s12882-015-0175-5, PubMed 26519164

Publications 2014

  1. Amro A, Waldum B, Dammen T, Miaskowski C, Os I (2014)
    Symptom clusters in patients on dialysis and their association with quality-of-life outcomes
    J Ren Care, 40 (1), 23-33
    DOI 10.1111/jorc.12051, PubMed 24438743
  2. Amro A, Waldum B, von der Lippe N, Brekke FB, Dammen T, Miaskowski C, Os I (2014)
    Symptom clusters predict mortality among dialysis patients in Norway: a prospective observational cohort study
    J Pain Symptom Manage, 49 (1), 27-35
    DOI 10.1016/j.jpainsymman.2014.04.005, PubMed 24858738
  3. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
    Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
    Ann Rheum Dis, 74 (8), 1515-21
    DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
  4. Bach-Gansmo T, Wien TN, Løndalen A, Halvorsen E (2014)
    Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake
    Clin Physiol Funct Imaging, 36 (3), 237-41
    DOI 10.1111/cpf.12219, PubMed 25524030
  5. Beitland S, Os I, Sunde K (2014)
    Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy
    Scientifica (Cairo), 2014, 235215
    DOI 10.1155/2014/235215, PubMed 25587490
  6. Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
    Uric acid and clinical correlates of endothelial function in kidney transplant recipients
    Clin Transplant, 28 (10), 1167-76
    DOI 10.1111/ctr.12435, PubMed 25124959
  7. Evenepoel P, Cooper K, Holdaas H, Messa P, Mourad G, Olgaard K, Rutkowski B, Schaefer H, Deng H, Torregrosa JV, Wuthrich RP, Yue S (2014)
    A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism
    Am. J. Transplant., 14 (11), 2545-2555
  8. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
    Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
    Hypertension, 63 (5), 991-9
    DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332
  9. Frich J, Lundin KE, Os I (2014)
    [J. Frich and colleagues reply]
    Tidsskr Nor Laegeforen, 134 (5), 496; discussion 497
    DOI 10.4045/tidsskr.14.0202, PubMed 24621892
  10. Holdaas H, Mjoen G (2014)
    Long-Term Risks of Kidney Donation: Age Known
    Am. J. Transplant., 14 (11), 2671-2672
  11. Kjeldsen SE, Os I (2014)
    Cost-effectiveness of therapeutic drugmonitoring in patients with resistant hypertension and improving patients' adherence
    J. Hypertens., 32 (12), 2357-2358
  12. Kjeldsen SE, Sørensen H, Fadl Elmula FE, Brekke M, Gjønnæss E, Hjørnholm U, Kjære VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Re: Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (15), 1449-50
    DOI 10.4045/tidsskr.14.0931, PubMed 25138398
  13. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
    Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
    J Acquir Immune Defic Syndr, 65 (4), e158-61
    DOI 10.1097/QAI.0000000000000055, PubMed 24577189
  14. Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
    Transplantation, 97 (2), 184-8
    DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385
  15. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Troseid M (2014)
    Monocyte Activation, but not Microbial Translocation, Is Independently Associated With Markers of Endovascular Dysfunction in HIV-Infected Patients Receiving cART
    JAIDS, 67 (4), 370-374
  16. Persu A, Fadl Elmula FEM, Jin Y, Os I, Kjeldsen SE, Staessen JA (2014)
    Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence
    Eur Cardiol, 9 (2), 110-114
    DOI 10.15420/ecr.2014.9.2.110, PubMed 30310496
  17. Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (1), 32-6
    DOI 10.4045/tidsskr.13.0276, PubMed 24429753
  18. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
    Microbial translocation and cardiometabolic risk factors in HIV infection
    AIDS Res Hum Retroviruses, 30 (6), 514-22
    DOI 10.1089/aid.2013.0280, PubMed 24521167
  19. von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
    Health related quality of life in patients in dialysis after renal graft loss and effect of gender
    BMC Womens Health, 14 (1), 34
    DOI 10.1186/1472-6874-14-34, PubMed 24580724
  20. Østevik L, Gunnes G, de Souza GA, Wien TN, Sørby R (2014)
    Nasal and ocular amyloidosis in a 15-year-old horse
    Acta Vet Scand, 56, 50
    DOI 10.1186/s13028-014-0050-6, PubMed 25159190

Publications 2013

  1. Brekke FB, Amro A, Hortemo Østhus TB, Dammen T, Waldum B, Os I (2013)
    Sleep complaints, depression and quality of life in Norwegian dialysis patients
    Clin Nephrol, 80 (2), 88-97
    DOI 10.5414/CN107916, PubMed 23611520
  2. Brekke FB, Waldum B, Amro A, Østhus TB, Dammen T, Gudmundsdottir H, Os I (2013)
    Self-perceived quality of sleep and mortality in Norwegian dialysis patients
    Hemodial Int, 18 (1), 87-94
    DOI 10.1111/hdi.12066, PubMed 23841517
  3. Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
    Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
    Clin Transplant, 28 (1), 134-40
    DOI 10.1111/ctr.12290, PubMed 24372653
  4. Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
    Endothelial dysfunction is associated with graft loss in renal transplant recipients
    Transplantation, 95 (5), 733-9
    DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481
  5. Eriksen BO, Løchen ML, Arntzen KA, Bertelsen G, Eilertsen BA, von Hanno T, Herder M, Jenssen TG, Mathisen UD, Melsom T, Njølstad I, Solbu MD, Toft I, Mathiesen EB (2013)
    Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population
    Kidney Int, 86 (1), 146-53
    DOI 10.1038/ki.2013.470, PubMed 24304885
  6. Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
    Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
    Hypertension, 62 (3), 526-32
    DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798
  7. Kjeldsen SE, Os I, Mahfoud F (2013)
    Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects
    EuroIntervention, 9 Suppl R, R7-9
    DOI 10.4244/EIJV9SRA1, PubMed 23732159
  8. Kjeldsen SE, Schultz M, Vinkenes K, Aksnes TA, Høieggen A (2013)
    [Blood Pressure Treatment--towards consensus on many things]
    Tidsskr Nor Laegeforen, 133 (21), 2226
    DOI 10.4045/tidsskr.13.1374, PubMed 24226313
  9. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
    Markers of microbial translocation predict hypertension in HIV-infected individuals
    HIV Med, 14 (6), 354-61
    DOI 10.1111/hiv.12015, PubMed 23332095
  10. Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
    The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
    Clin Transplant, 28 (1), 120-6
    DOI 10.1111/ctr.12288, PubMed 24351078
  11. Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, Solbu M, White S, Chadban S, Jenssen T (2013)
    Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study
    BMC Cardiovasc Disord, 13, 115
    DOI 10.1186/1471-2261-13-115, PubMed 24330812
  12. Waldum B, Os I (2013)
    The cardiorenal syndrome: what the cardiologist needs to know
    Cardiology, 126 (3), 175-86
    DOI 10.1159/000353261, PubMed 24022166

Publications 2012

  1. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
    Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
    J Acquir Immune Defic Syndr, 59 (2), e24-5
    DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
  2. Friberg AS, Lundgren T, Malm H, Felldin M, Nilsson B, Jenssen T, Kyllönen L, Tufveson G, Tibell A, Korsgren O (2012)
    Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients
    Transplantation, 93 (6), 632-8
    DOI 10.1097/TP.0b013e3182455912, PubMed 22258287
  3. Fyhrquist F, Eriksson A, Saijonmaa O, Nordestgaard BG, Kontula K, de Faire U, Ibsen H, Kjeldsen S, Os I, Dahlöf B (2012)
    Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy
    J Renin Angiotensin Aldosterone Syst, 14 (3), 227-34
    DOI 10.1177/1470320312460292, PubMed 23077078
  4. Gudmundsdottir H, Høieggen A, Stenehjem A, Waldum B, Os I (2012)
    Hypertension in women: latest findings and clinical implications
    Ther Adv Chronic Dis, 3 (3), 137-46
    DOI 10.1177/2040622312438935, PubMed 23251774
  5. Høieggen A, Os I (2012)
    [Serious illness--tough treatment]
    Tidsskr Nor Laegeforen, 132 (14), 1624-5
    DOI 10.4045/tidsskr.12.0424, PubMed 22875129
  6. Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
    Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
    Transplantation, 94 (5), 492-8
    DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806
  7. Manner IW, Baekken M, Oektedalen O, Os I (2012)
    Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
    Blood Press, 21 (5), 311-9
    DOI 10.3109/08037051.2012.680742, PubMed 22564000
  8. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
    Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
    J Clin Hypertens (Greenwich), 15 (2), 101-6
    DOI 10.1111/jch.12029, PubMed 23339727
  9. Melsom T, Mathisen UD, Eilertsen BA, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6)
    Clin J Am Soc Nephrol, 7 (11), 1801-10
    DOI 10.2215/CJN.02980312, PubMed 22917703
  10. Nordstrand N, Hertel JK, Hofsø D, Sandbu R, Saltvedt E, Røislien J, Os I, Hjelmesaeth J (2012)
    A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity
    Surgery, 151 (5), 674-80
    DOI 10.1016/j.surg.2011.12.007, PubMed 22261295
  11. Osthus TB, von der Lippe N, Ribu L, Rustøen T, Leivestad T, Dammen T, Os I (2012)
    Health-related quality of life and all-cause mortality in patients with diabetes on dialysis
    BMC Nephrol, 13, 78
    DOI 10.1186/1471-2369-13-78, PubMed 22863310
  12. Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930
  13. Waldum B, Stubnova V, Westheim AS, Omland T, Grundtvig M, Os I (2012)
    Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
    Clin Kidney J, 6 (1), 55-62
    DOI 10.1093/ckj/sfs174, PubMed 24422171
  14. Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T, Os I (2012)
    Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry
    J Am Coll Cardiol, 59 (4), 371-8
    DOI 10.1016/j.jacc.2011.10.864, PubMed 22261159
  15. Østhus TB, Preljevic VT, Sandvik L, Leivestad T, Nordhus IH, Dammen T, Os I (2012)
    Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey
    Health Qual Life Outcomes, 10, 46
    DOI 10.1186/1477-7525-10-46, PubMed 22559816

Publications 2011

  1. Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C (2011)
    Everolimus and long-term outcomes in renal transplantation
    Transplantation, 92 (3 Suppl), S3-26
    DOI 10.1097/TP.0b013e3182230900, PubMed 21799392
  2. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
    Inflammation-associated graft loss in renal transplant recipients
    Nephrol Dial Transplant, 26 (11), 3756-61
    DOI 10.1093/ndt/gfr163, PubMed 21511816
  3. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
    Rosuvastatin in diabetic hemodialysis patients
    J Am Soc Nephrol, 22 (7), 1335-41
    DOI 10.1681/ASN.2010090987, PubMed 21566054
  4. Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
    Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
    Transplantation, 92 (4), 410-8
    DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773
  5. Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ (2011)
    Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children
    Scand J Trauma Resusc Emerg Med, 19, 44
    DOI 10.1186/1757-7241-19-44, PubMed 21798000
  6. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
    Impaired fasting glucose is associated with renal hyperfiltration in the general population
    Diabetes Care, 34 (7), 1546-51
    DOI 10.2337/dc11-0235, PubMed 21593291
  7. Nordstrand N, Gjevestad E, Dinh KN, Hofsø D, Røislien J, Saltvedt E, Os I, Hjelmesæth J (2011)
    The relationship between various measures of obesity and arterial stiffness in morbidly obese patients
    BMC Cardiovasc Disord, 11, 7
    DOI 10.1186/1471-2261-11-7, PubMed 21284837
  8. Os I, Gudmundsdottir H, Draganov B, von der Lippe E (2011)
    Sterile peritonitis associated with amino acid-containing dialysate--a single center experience in Norway
    Perit Dial Int, 31 (1), 103
    DOI 10.3747/pdi.2010.00298, PubMed 21282392
  9. Preljevic VT, Østhus TB, Sandvik L, Bringager CB, Opjordsmoen S, Nordhus IH, Os I, Dammen T (2011)
    Psychiatric disorders, body mass index and C-reactive protein in dialysis patients
    Gen Hosp Psychiatry, 33 (5), 454-61
    DOI 10.1016/j.genhosppsych.2011.06.010, PubMed 21831445
  10. Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
    A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
    Blood Purif, 32 (3), 151-5
    DOI 10.1159/000325227, PubMed 21659742
  11. Strøm EH, Sund S, Reier-Nilsen M, Dørje C, Leren TP (2011)
    Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrence
    Ultrastruct Pathol, 35 (3), 139-45
    DOI 10.3109/01913123.2010.551578, PubMed 21323422
  12. Østhus TB, Preljevic V, Sandvik L, Dammen T, Os I (2011)
    Renal transplant acceptance status, health-related quality of life and depression in dialysis patients
    J Ren Care, 38 (2), 98-106
    DOI 10.1111/j.1755-6686.2011.00254.x, PubMed 21917125

Publications 2010

  1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
    Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
    J Acquir Immune Defic Syndr, 53 (3), 419-20
    DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
  2. Beitland S, Moen H, Os I (2010)
    Acute kidney injury with renal replacement therapy in trauma patients
    Acta Anaesthesiol Scand, 54 (7), 833-40
    DOI 10.1111/j.1399-6576.2010.02253.x, PubMed 20528778
  3. Bryhni B, Arnesen E, Jenssen TG (2010)
    Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
    BMC Endocr Disord, 10, 21
    DOI 10.1186/1472-6823-10-21, PubMed 21162746
  4. Hedner T, Oparil S, Narkiewicz K, Os I (2010)
    Cardiovascular risks in HIV patients
    Blood Press, 19 (6), 325-7
    DOI 10.3109/08037051.2010.537016, PubMed 21080761
  5. Manner IW, Baekken M, Oektedalen O, Sandvik L, Os I (2010)
    Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure
    Blood Press, 19 (3), 188-95
    DOI 10.3109/08037051.2010.483055, PubMed 20482442
  6. Nordestgaard BG, Kontula K, Benn M, Dahlöf B, de Faire U, Edelman JM, Eliasson E, Fyhrquist F, Hille DA, Ibsen H, Lyle PA, Berg K, Sandberg M, Sethi AA, Wong PH, Os I (2010)
    Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study
    Pharmacogenet Genomics, 20 (2), 77-85
    DOI 10.1097/FPC.0b013e328333f70b, PubMed 20065889
  7. Strøm EH, Reinholt FP, Midtvedt K (2010)
    JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
    Transpl Infect Dis, 13 (1), 93-4
    DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773
  8. Waldum B, Westheim AS, Sandvik L, Flønaes B, Grundtvig M, Gullestad L, Hole T, Os I (2010)
    Renal function in outpatients with chronic heart failure
    J Card Fail, 16 (5), 374-80
    DOI 10.1016/j.cardfail.2010.01.001, PubMed 20447572
  9. Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, Lindholm L, Dahlöf B, Devereux RB, Okin PM, Wachtell K (2010)
    Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study
    Am J Hypertens, 23 (8), 845-51
    DOI 10.1038/ajh.2010.89, PubMed 20431530
  10. Østhus TB, Dammen T, Sandvik L, Bruun CM, Nordhus IH, Os I (2010)
    Health-related quality of life and depression in dialysis patients: associations with current smoking
    Scand J Urol Nephrol, 44 (1), 46-55
    DOI 10.3109/00365590903449324, PubMed 20030569

Publications 2009

  1. Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group (2009)
    Cardiovascular disease in patients with renal disease: the role of statins
    Curr Med Res Opin, 25 (1), 271-85
    DOI 10.1185/03007990802622064, PubMed 19210158
  2. Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
    Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
    J Hum Hypertens, 24 (8), 505-13
    DOI 10.1038/jhh.2009.94, PubMed 20010619
  3. Krämer BK, Klinger M, Wlodarczyk Z, Ostrowski M, Midvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Vítko S, Senatorski G, Salmela K, Nordström J (2009)
    Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results
    Clin Transplant, 24 (1), E1-9
    DOI 10.1111/j.1399-0012.2009.01162.x, PubMed 19925464
  4. Manner I, Sagedal S, Røger M, Os I (2009)
    Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure
    Clin Nephrol, 72 (3), 224-8
    DOI 10.5414/cnp72224, PubMed 19761730
  5. Solbu MD, Jenssen TG, Eriksen BO, Toft I (2009)
    Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study
    Metabolism, 58 (3), 408-15
    DOI 10.1016/j.metabol.2008.10.016, PubMed 19217459

Publications 2008

  1. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
    Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy
    J Hypertens, 26 (11), 2126-33
    DOI 10.1097/HJH.0b013e32830ef5fb, PubMed 18854751
  2. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
    Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
    Nephrol Dial Transplant, 23 (10), 3130-7
    DOI 10.1093/ndt/gfn236, PubMed 18469311
  3. Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O (2008)
    Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals
    HIV Med, 10 (1), 44-52
    DOI 10.1111/j.1468-1293.2008.00655.x, PubMed 19018875
  4. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008)
    Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
    Metabolism, 57 (10), 1422-7
    DOI 10.1016/j.metabol.2008.05.012, PubMed 18803948
  5. Flaa A, Eide IK, Kjeldsen SE, Rostrup M (2008)
    Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study
    Hypertension, 52 (2), 336-41
    DOI 10.1161/HYPERTENSIONAHA.108.111625, PubMed 18574074
  6. Gudmundsdottir H, Strand AH, Høieggen A, Reims HM, Westheim AS, Eide IK, Kjeldsen SE, Os I (2008)
    Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men
    Blood Press, 17 (2), 94-103
    DOI 10.1080/08037050801972923, PubMed 18568698
  7. Gudmundsdottir H, Strand AH, Kjeldsen SE, Høieggen A, Os I (2008)
    Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men
    J Clin Hypertens (Greenwich), 10 (11), 814-21
    DOI 10.1111/j.1751-7176.2008.00032.x, PubMed 19128269
  8. Krogenaes AK, Taubøll E, Stien A, Oskam IC, Lyche JL, Dahl E, Thomassen RF, Sweeney T, Ropstad E (2008)
    Valproate affects reproductive endocrine function, testis diameter and some semen variables in non-epileptic adolescent goat bucks
    Theriogenology, 70 (1), 15-26
    DOI 10.1016/j.theriogenology.2008.01.029, PubMed 18394693
  9. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T (2008)
    Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
    Nephrol Dial Transplant, 23 (9), 2818-26
    DOI 10.1093/ndt/gfn148, PubMed 18400822
  10. Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators (2008)
    Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy
    Hypertension, 52 (1), 100-6
    DOI 10.1161/HYPERTENSIONAHA.108.110064, PubMed 18504323
  11. Os I, Devereux RB, Okin PM (2008)
    Gender differences in left ventricular hypertrophy regression - Response
    Hypertension, 51 (6), E59
  12. Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, Hille DA, Lyle PA, Okin PM, Dahlöf B, Oparil S (2008)
    Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study
    Hypertension, 51 (4), 1103-8
    DOI 10.1161/HYPERTENSIONAHA.107.105296, PubMed 18259029
  13. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    DOI 10.1093/ndt/gfn355, PubMed 18577532
  14. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I (2008)
    Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study
    Atherosclerosis, 201 (2), 398-406
    DOI 10.1016/j.atherosclerosis.2008.02.027, PubMed 18405901
  15. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I (2008)
    Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
    Atherosclerosis, 204 (2), 503-8
    DOI 10.1016/j.atherosclerosis.2008.11.002, PubMed 19091314
  16. Strand A, Kjeldsen SE, Gudmundsdottir H, Os I, Smith G, Bjørnerheim R (2008)
    Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years
    Eur J Echocardiogr, 9 (1), 34-9
    DOI 10.1016/j.euje.2007.02.007, PubMed 17448731

Publications 2007

  1. Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
    Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
    Metabolism, 56 (11), 1470-7
    DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096
  2. Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, Zannad F, AURORA Study Group (2007)
    Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
    Kidney Blood Press Res, 30 (5), 314-22
    DOI 10.1159/000106803, PubMed 17671394
  3. Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS (2007)
    The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
    J Cardiovasc Pharmacol, 49 (1), 27-32
    DOI 10.1097/FJC.0b013e31802bdd8c, PubMed 17261960
  4. Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO (2007)
    Metabolic risk factors associated with serum creatinine in a non-diabetic population
    Eur J Epidemiol, 22 (10), 707-13
    DOI 10.1007/s10654-007-9164-8, PubMed 17653600
  5. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T (2007)
    Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study
    Diabetologia, 50 (8), 1607-14
    DOI 10.1007/s00125-007-0715-z, PubMed 17558484
  6. Midtvedt K, Bjorang O, Letting AS (2007)
    Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
    Clin Transplant, 21 (4), 571-3
    DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722
  7. Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B (2007)
    Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)
    Am J Cardiol, 100 (5), 855-9
    DOI 10.1016/j.amjcard.2007.03.109, PubMed 17719333
  8. Stenehjem AE, Bjørnerheim R, Os I (2007)
    From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion
    Blood Press, 16 (2), 87-94
    DOI 10.1080/08037050701287703, PubMed 17612906
  9. Stenehjem AE, Vahter M, Nermell B, Aasen J, Lierhagen S, Mørland J, Jacobsen D (2007)
    Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)
    Clin Toxicol (Phila), 45 (4), 424-8
    DOI 10.1080/15563650701232489, PubMed 17486487
  10. Strand A, Gudmundsdottir H, Høieggen A, Fossum E, Bjørnerheim R, Os I, Kjeldsen SE (2007)
    Increased hematocrit before blood pressure in men who develop hypertension over 20 years
    J Am Soc Hypertens, 1 (6), 400-6
    DOI 10.1016/j.jash.2007.07.002, PubMed 20409872

Publications 2006

  1. Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
    Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
    J Hum Hypertens, 20 (11), 860-6
    DOI 10.1038/sj.jhh.1002087, PubMed 16988754
  2. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M (2006)
    Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges
    Hypertension, 47 (3), 396-402
    DOI 10.1161/01.HYP.0000203952.27988.79, PubMed 16446389
  3. Gudmundsdottir H, Aksnes H, Heldal K, Krogh A, Froyshov S, Rudberg N, Os I (2006)
    Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?
    Clin Nephrol, 66 (5), 380-5
    DOI 10.5414/cnp66380, PubMed 17140168
  4. Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A (2006)
    N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy
    Cardiology, 106 (2), 102-8
    DOI 10.1159/000092743, PubMed 16636540
  5. Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
    Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
    J Med Virol, 78 (3), 384-93
    DOI 10.1002/jmv.20551, PubMed 16419108
  6. Os I (2006)
    Comparison of doxazosin GITS and standard doxazosin in the treatment of high blood pressure
    Int J Clin Pharmacol Ther, 44 (3), 99-106
    DOI 10.5414/cpp44099, PubMed 16550731
  7. Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S (2006)
    Treatment of isolated systolic hypertension in diabetes mellitus type 2
    Diabetes Obes Metab, 8 (4), 381-7
    DOI 10.1111/j.1463-1326.2005.00523.x, PubMed 16776744
  8. Raeder H, Bjørkhaug L, Johansson S, Mangseth K, Sagen JV, Hunting A, Følling I, Johansen O, Bjørgaas M, Paus PN, Søvik O, Molven A, Njølstad PR (2006)
    A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry
    Diabetes, 55 (6), 1899-903
    DOI 10.2337/db05-1677, PubMed 16731861
  9. Stenehjem AE, Gudmundsdottir H, Os I (2006)
    Office blood pressure measurements overestimate blood pressure control in renal transplant patients
    Blood Press Monit, 11 (3), 125-33
    DOI 10.1097/01.mbp.0000209080.24870.2d, PubMed 16702821
  10. Stenehjem AE, Os I (2006)
    Clinical utility and applicability of smoothness index, normalized smoothness index and individualized RDH index during treatment of essential hypertension
    Blood Press, 15 (5), 281-90
    DOI 10.1080/08037050600996628, PubMed 17380846
  11. Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjørnerheim R, Kjeldsen SE (2006)
    Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
    J Hypertens, 24 (5), 905-13
    DOI 10.1097/01.hjh.0000222761.07477.7b, PubMed 16612253
  12. Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
    No effect of increased water intake on blood viscosity and cardiovascular risk factors
    Br J Nutr, 96 (6), 993-6
    DOI 10.1017/bjn20061969, PubMed 17181872

Publications 2005

  1. Fellström B, Zannad F, Schmieder R, Holdaas H, Jardine A, Rose H, Wilpshaar W, AURORA Study Group (2005)
    Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study
    Curr Control Trials Cardiovasc Med, 6 (1), 9
    DOI 10.1186/1468-6708-6-9, PubMed 15910680
  2. Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D (2005)
    Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases
    Clin Nephrol, 64 (3), 190-7
    DOI 10.5414/cnp64190, PubMed 16175943
  3. Høieggen A, Os I, Kjeldsen SE (2005)
    [Uric acid--more deleterious than we thought?]
    Tidsskr Nor Laegeforen, 125 (10), 1330-2
    PubMed 15909004
  4. Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A (2005)
    A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients
    Cardiology, 103 (3), 148-55
    DOI 10.1159/000084584, PubMed 15785019
  5. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG (2005)
    Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
    J Clin Endocrinol Metab, 91 (1), 145-53
    DOI 10.1210/jc.2005-1775, PubMed 16263815
  6. Kjeldsen SE, Westheim AS, Os I (2005)
    More heat to support aggressive blood pressure lowering: the FEVER study
    J Hypertens, 23 (12), 2145-6
    DOI 10.1097/01.hjh.0000194123.27475.25, PubMed 16269953
  7. Kjeldsen SE, Westheim AS, Os I (2005)
    Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE
    Curr Hypertens Rep, 7 (3), 155-7
    DOI 10.1007/s11906-005-0001-8, PubMed 15913486
  8. Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2005)
    Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
    J Hypertens, 23 (4), 891-8
    DOI 10.1097/01.hjh.0000163160.60234.15, PubMed 15775796
  9. Reims HM, Sevre K, Fossum E, Mellem H, Eide IK, Kjeldsen SE (2005)
    Adrenaline during mental stress in relation to fitness, metabolic risk factors and cardiovascular responses in young men
    Blood Press, 14 (4), 217-26
    DOI 10.1080/08037050510034275, PubMed 16126555
  10. Reims HM, Sevre K, Høieggen A, Fossum E, Eide I, Kjeldsen SE (2005)
    Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity
    Blood Press, 14 (3), 159-69
    DOI 10.1080/08037050510034176, PubMed 16036496
  11. Saelen MG, Prøsch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, Paulsen D, Skjønsberg H, Os I (2005)
    Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function
    Blood Press, 14 (3), 170-6
    DOI 10.1080/08037050510008959, PubMed 16036497
  12. Tomson J, Os I, Lip GY (2005)
    Hormone replacement use and cardiovascular function and structure in postmenopausal women
    Blood Press, 14 (1), 3-5
    DOI 10.1080/08037050510008841, PubMed 15823940
  13. Vítko S, Klinger M, Salmela K, Wlodarczyk Z, Tydèn G, Senatorski G, Ostrowski M, Fauchald P, Kokot F, Stefoni S, Perner F, Claesson K, Castagneto M, Heemann U, Carmellini M, Squifflet JP, Weber M, Segoloni G, Bäckman L, Sperschneider H, Krämer BK (2005)
    Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study
    Transplantation, 80 (12), 1734-41
    DOI 10.1097/01.tp.0000188300.26762.74, PubMed 16378069

Publications 2004

  1. Fossum E, Høieggen A, Reims HM, Moan A, Rostrup M, Eide I, Kjeldsen SE (2004)
    High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
    Blood Press, 13 (2), 89-94
    DOI 10.1080/08037050310031008, PubMed 15182111
  2. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Ibsen H, Julius S, Kjeldsen SE (2004)
    Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy
    J Hum Hypertens, 18 (6), 375-80
    DOI 10.1038/sj.jhh.1001712, PubMed 15057253
  3. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, LIFE Study Group (2004)
    The impact of serum uric acid on cardiovascular outcomes in the LIFE study
    Kidney Int, 65 (3), 1041-9
    DOI 10.1111/j.1523-1755.2004.00484.x, PubMed 14871425
  4. Kjeldsen SE, Os I, Hedner T, Himmelmann A (2004)
    Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers
    Blood Press, 13 (6), 324-5
    DOI 10.1080/08037050410010416, PubMed 15771214
  5. Os I, Oparil S, Gerdts E, Høieggen A (2004)
    Essential hypertension in women
    Blood Press, 13 (5), 272-8
    DOI 10.1080/08037050410024330, PubMed 15545149
  6. Reims HM, Fossum E, Høieggen A, Moan A, Eide I, Kjeldsen SE (2004)
    Adrenal medullary overactivity in lean, borderline hypertensive young men
    Am J Hypertens, 17 (7), 611-8
    DOI 10.1016/j.amjhyper.2004.03.676, PubMed 15233980
  7. Reims HM, Sevre K, Fossum E, Høieggen A, Eide I, Kjeldsen SE (2004)
    Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men
    Blood Press, 13 (5), 287-94
    DOI 10.1080/08037050410016474, PubMed 15545152
  8. Reims HM, Sevre K, Fossum E, Høieggen A, Mellem H, Kjeldsen SE (2004)
    Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men
    J Hypertens, 22 (10), 2007-15
    DOI 10.1097/00004872-200410000-00025, PubMed 15361774
  9. Stenehjem AE, Os I (2004)
    Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension
    Blood Press, 13 (4), 214-24
    DOI 10.1080/08037050410021432, PubMed 15581335

Publications 2003

  1. Fellström BC, Holdaas H, Jardine AG (2003)
    Why do we need a statin trial in hemodialysis patients?
    Kidney Int Suppl (84), S204-6
    DOI 10.1046/j.1523-1755.63.s84.10.x, PubMed 12694345
  2. Höieggen A, Fossum E, Reims H, Kjeldsen SE (2003)
    Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy
    Blood Press, 12 (2), 104-10
    DOI 10.1080/08037050310060508, PubMed 12797630
  3. Kjeldsen SE, Fossum E, Reims HM, Høieggen A (2003)
    Hypertension treatment and stroke prevention
    Blood Press, 12 (5-6), 264-8
    DOI 10.1080/08037050310016501, PubMed 14763656
  4. Kjeldsen SE, Os I (2003)
    Hypertension in very old people
    J Hypertens, 21 (12), 2249-50
    DOI 10.1097/00004872-200312000-00011, PubMed 14654743
  5. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
    Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
    J Intern Med, 253 (2), 232-9
    DOI 10.1046/j.1365-2796.2003.01110.x, PubMed 12542565

Publications 2002

  1. Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA (2002)
    Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient
    Nephrol Dial Transplant, 17 (11), 2023-5
    DOI 10.1093/ndt/17.11.2023, PubMed 12401867
  2. Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A (2002)
    Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction
    Blood Press, 11 (6), 377-84
    DOI 10.1080/080370502321095357, PubMed 12523682
  3. Os I (2002)
    [Sex differences in the risk for coronary heart disease]
    Tidsskr Nor Laegeforen, 122 (22), 2225
    PubMed 12426905
  4. Os I, Djurovic S, Seljeflot I, Berg K (2002)
    Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?
    J Intern Med, 251 (3), 223-7
    DOI 10.1046/j.1365-2796.2002.00950.x, PubMed 11886481

Publications 2001

  1. Boulatov VA, Stenehjem A, Os I (2001)
    Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension
    Am J Hypertens, 14 (4 Pt 1), 338-44
    DOI 10.1016/s0895-7061(00)01278-4, PubMed 11336179
  2. Bulatov VA, Stenehjem A, Os I (2001)
    Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension
    J Hypertens, 19 (8), 1473-8
    DOI 10.1097/00004872-200108000-00016, PubMed 11518856
  3. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
    Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
    Transplantation, 72 (1), 107-11
    DOI 10.1097/00007890-200107150-00021, PubMed 11468543
  4. Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, Godøy J, Dunlop O, von der Lippe B (2001)
    Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis
    Scand J Urol Nephrol, 35 (4), 330-3
    DOI 10.1080/003655901750425945, PubMed 11676362
  5. Reims HM, Høieggen A, Fossum E, Rostrup M, Eide I, Kjeldsen SE (2001)
    Glucose disposal rates calculated from 60- to 90-minute isoglycemic hyperinsulinemic glucose clamp correlate with cardiovascular risk factors in borderline hypertensive young men
    Metabolism, 50 (10), 1175-80
    DOI 10.1053/meta.2001.26761, PubMed 11586489
  6. Ross AE, Flaa A, Høieggen A, Reims H, Eide IK, Kjeldsen SE (2001)
    Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects
    Scand Cardiovasc J, 35 (5), 307-12
    DOI 10.1080/140174301317116271, PubMed 11771821

Publications 2000

  1. Belkić K, Schwartz J, Schnall P, Pickering TG, Steptoe A, Marmot M, Theorell T, Fossum E, Høieggen A, Moan A, Rostrup M, Kjeldsen SE (2000)
    Evidence for mediating econeurocardiologic mechanisms
    Occup Med, 15 (1), 117-62
    PubMed 10620789
  2. Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
    The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
    Thromb Res, 98 (1), 19-27
    DOI 10.1016/s0049-3848(99)00233-9, PubMed 10706930
  3. Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P (2000)
    Treatment of hypertension in patients with type-2 diabetes mellitus
    Blood Press, 9 (6), 363-4
    PubMed 11212066
  4. Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P (2000)
    Treatment of hypertension in patients with type-2 diabetes mellitus
    J Hypertens, 18 (9), 1345-6
    DOI 10.1097/00004872-200018090-00023, PubMed 10994767
  5. Kjeldsen SE, Westheim AS, Os I (2000)
    INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study
    Lancet, 356 (9245), 1929-30
    DOI 10.1016/s0140-6736(05)73480-2, PubMed 11130406
  6. Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland K, Larsen A, Midtbo K, Westheim A (2000)
    The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
    J Intern Med, 247 (4), 433-41
    DOI 10.1046/j.1365-2796.2000.00675.x, PubMed 10792556
  7. Reims H, Høieggen A, Fossum E, Kjeldsen SE (2000)
    Assessment of insulin sensitivity by 90 min isoglycaemic hyperinsulinaemic glucose clamp in healthy young men
    Blood Press, 9 (2-3), 121-5
    DOI 10.1080/080370500453456, PubMed 10855735
 
Page visits: 6088